Project Details
Description
A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone to Chemotherapy plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/14 → 7/31/19 |
Funding
- NRG ONCOLOGY FOUNDATION, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.